Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Catalyst Pharm Inc (CPRX)

Catalyst Pharm Inc (CPRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 523,128
  • Shares Outstanding, K 102,978
  • Annual Sales, $ 119,070 K
  • Annual Income, $ 74,980 K
  • 60-Month Beta 1.34
  • Price/Sales 4.37
  • Price/Cash Flow 12.72
  • Price/Book 2.87
Trade CPRX with:

Options Overview Details

View History
  • Implied Volatility 62.03%
  • Historical Volatility 30.54%
  • IV Percentile 12%
  • IV Rank 15.91%
  • IV High 155.93% on 12/07/20
  • IV Low 44.26% on 09/09/21
  • Put/Call Vol Ratio 0.19
  • Today's Volume 114
  • Volume Avg (30-Day) 259
  • Put/Call OI Ratio 0.48
  • Today's Open Interest 5,724
  • Open Int (30-Day) 7,417

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate 0.10
  • Number of Estimates 4
  • High Estimate 0.10
  • Low Estimate 0.09
  • Prior Year 0.11
  • Growth Rate Est. (year over year) -9.09%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.81 +7.90%
on 09/20/21
5.68 -8.63%
on 09/01/21
-0.28 (-5.12%)
since 08/27/21
3-Month
4.81 +7.90%
on 09/20/21
6.24 -16.76%
on 08/13/21
-0.86 (-14.21%)
since 06/25/21
52-Week
2.88 +80.52%
on 11/02/20
6.24 -16.76%
on 08/13/21
+2.03 (+64.24%)
since 09/25/20

Most Recent Stories

More News
Catalyst Pharmaceuticals to Participate at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines...

CPRX : 5.19 (+2.17%)
3 Pharmaceutical Stocks Under $10 to Buy in September

The pharmaceutical industry’s increased focus on developing better treatments for many of today's most complex diseases should help it to grow for the foreseeable future. However, because highly priced...

AMRX : 5.33 (+0.38%)
CPRX : 5.19 (+2.17%)
KMDA : 5.40 (+0.93%)
Catalyst Pharmaceuticals to Participate in Two Upcoming Investor Conferences

Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines...

CPRX : 5.19 (+2.17%)
Why Is Catalyst (CPRX) Down 12.6% Since Last Earnings Report?

Catalyst (CPRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

CPRX : 5.19 (+2.17%)
3 Under the Radar Pharmaceutical Stocks to Add to Your Watchlist

The pharmaceutical industry is expected to attract significant investor attention in the coming months as the demand for vaccines and therapies continues to soar with the resurgence of COVID-19 cases globally....

CPRX : 5.19 (+2.17%)
KMDA : 5.40 (+0.93%)
OPNT : 24.53 (-2.66%)
Catalyst Pharmaceuticals Appoints Mary Coleman as Vice President, Head of Investor Relations

Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing and commercializing novel high-quality medicines...

CPRX : 5.19 (+2.17%)
Catalyst (CPRX) Up More Than 20% in Past 3 Months: Here's Why

Catalyst's (CPRX) lead drug, Firdapse, is approved for treating Lambert-Eaton myasthenic syndrome. The drug has seen solid uptake since its launch.

CPRX : 5.19 (+2.17%)
GLMD : 3.02 (-0.98%)
RLMD : 26.50 (-8.93%)
LRMR : 12.74 (+2.49%)
Catalyst (CPRX) Q2 Earnings Top Estimates, Revenues Rise Y/Y

Catalyst's (CPRX) earnings and revenues beat estimates in the second quarter of 2021. Shares inch up in after-hours trading.

CPRX : 5.19 (+2.17%)
USNA : 91.47 (+1.71%)
GLMD : 3.02 (-0.98%)
LRMR : 12.74 (+2.49%)
Catalyst Pharmaceutical (CPRX) Q2 Earnings and Revenues Top Estimates

Catalyst (CPRX) delivered earnings and revenue surprises of 77.78% and 16.37%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

CPRX : 5.19 (+2.17%)
Catalyst Pharmaceuticals Announces Second Quarter 2021 Financial Results and Provides Corporate Update

-Q2 2021 Total Net Revenues of $36.4 Million Reflect Strong Quarter over Quarter Growth

CPRX : 5.19 (+2.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, including Lambert-Eaton myasthenic syndrome (LEMS), anti-MuSK antibody positive myasthenia gravis...

See More

Key Turning Points

3rd Resistance Point 5.46
2nd Resistance Point 5.36
1st Resistance Point 5.27
Last Price 5.19
1st Support Level 5.08
2nd Support Level 4.98
3rd Support Level 4.89

See More

52-Week High 6.24
Last Price 5.19
Fibonacci 61.8% 4.95
Fibonacci 50% 4.56
Fibonacci 38.2% 4.16
52-Week Low 2.88

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar